Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder:A systematic review and meta-analyses

Autor: Erica Ydedahl-Jensen, Trine Gerner, Helle B Krogh, Mathilde Holmskov, Erlend Faltinsen, Ole Jakob Storebø, Frederik L Magnusson, Christian Gluud, Adnan Todorovac, Erik Simonsen

Publikováno v: Krogh, H B, Storebø, O J, Faltinsen, E, Todorovac, A, Ydedahl-Jensen, E, Magnusson, F L, Holmskov, M, Gerner, T, Gluud, C & Simonsen, E 2019, ' Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder : A systematic review and meta-analyses ', BMJ Open, vol. 9, no. 3, e026478 . https://doi.org/10.1136/bmjopen-2018-026478
BMJ Open

ObjectiveTo assess the methodological advantages and disadvantages of parallel and crossover designs in randomised clinical trials on methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).DesignSecondary an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b6cd1d29cd68a07aca0c0382c9ac47
https://findresearcher.sdu.dk:8443/ws/files/193060537/e026478.full.pdf